2023, 18 October
AliBERT achieves it first successful application i...
A successful proof-of-concept for AliBERT, the first French-language model specialized in the biomedical field. In partnership with a major French ...
A successful proof-of-concept for AliBERT, the first French-language model specialized in the biomedical field. In partnership with a major French ...
A promising algorithm for early diagnosis of Acid Sphingomyelinase Deficiency (ASMD) in patients with unexplained Interstitial Lung Disease...
Newly diagnosed metastatic melanoma patients are often treated with molecular targeted therapy (TT) or with immunotherapy (IO).